Cargando…
Promises and perils of the FDA's over-the-counter naloxone reclassification
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366474/ https://www.ncbi.nlm.nih.gov/pubmed/37497396 http://dx.doi.org/10.1016/j.lana.2023.100518 |
| _version_ | 1785077177304219648 |
|---|---|
| author | Zhu, David T. Tamang, Suzanne Humphreys, Keith |
| author_facet | Zhu, David T. Tamang, Suzanne Humphreys, Keith |
| author_sort | Zhu, David T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10366474 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103664742023-07-26 Promises and perils of the FDA's over-the-counter naloxone reclassification Zhu, David T. Tamang, Suzanne Humphreys, Keith Lancet Reg Health Am Comment Elsevier 2023-05-22 /pmc/articles/PMC10366474/ /pubmed/37497396 http://dx.doi.org/10.1016/j.lana.2023.100518 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Comment Zhu, David T. Tamang, Suzanne Humphreys, Keith Promises and perils of the FDA's over-the-counter naloxone reclassification |
| title | Promises and perils of the FDA's over-the-counter naloxone reclassification |
| title_full | Promises and perils of the FDA's over-the-counter naloxone reclassification |
| title_fullStr | Promises and perils of the FDA's over-the-counter naloxone reclassification |
| title_full_unstemmed | Promises and perils of the FDA's over-the-counter naloxone reclassification |
| title_short | Promises and perils of the FDA's over-the-counter naloxone reclassification |
| title_sort | promises and perils of the fda's over-the-counter naloxone reclassification |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366474/ https://www.ncbi.nlm.nih.gov/pubmed/37497396 http://dx.doi.org/10.1016/j.lana.2023.100518 |
| work_keys_str_mv | AT zhudavidt promisesandperilsofthefdasoverthecounternaloxonereclassification AT tamangsuzanne promisesandperilsofthefdasoverthecounternaloxonereclassification AT humphreyskeith promisesandperilsofthefdasoverthecounternaloxonereclassification |